Table 2 Effect of PALB2 Mutations on Kidney Cancer Risk
From: Recurrent PALB2 mutations and the risk of cancers of bladder or kidney in Polish population
| Mutation subjects | Number of carriers/total (frequency %) | OR | 95% CI | p-value |
|---|---|---|---|---|
| 509_510delGA | ||||
| Controls | 7/4702 (0.15) | 1.0 | ||
| Cases | 1/810 (0.1) | 0.8 | 0.10–6.75 | 0.86 |
| 172_175delTTGT | ||||
| Controls | 3/4702 (0.06) | 1.0 | ||
| Cases | 1/810 (0.1) | 1.9 | 0.20–18.6 | 0.56 |
| Any PALB2 mutation | ||||
| Controls | 10/4702 (0.21) | 1.0 | ||
| Cases | 2/810 (0.24) | 1.2 | 0.25–5.13 | 0.84 |